ADBiotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2,692	3,015	1,179	1,195	2,438
Short-Term Investments	630	630	4,547	120	96
Trading Asset Securities	-	5,769	2,901	1,465	308.11
Cash & Short-Term Investments	3,322	9,414	8,628	2,781	2,842
Cash Growth	-42.96%	9.11%	210.28%	-2.17%	-
Accounts Receivable	1,320	1,596	1,873	3,497	1,733
Other Receivables	200.21	8.07	47.67	3.28	383.27
Receivables	1,520	1,604	2,321	3,500	2,117
Inventory	2,373	2,265	2,952	2,106	1,774
Prepaid Expenses	50.54	16.83	59.27	81.21	394.93
Other Current Assets	565.85	117.63	163.87	204.67	121.52
Total Current Assets	7,831	13,417	14,123	8,672	7,249
Property, Plant & Equipment	10,085	10,312	10,319	10,287	7,423
Long-Term Investments	1,362	1,585	6,491	1,878	3,938
Goodwill	1,126	1,126	-	-	-
Other Intangible Assets	963.69	1,029	2.4	5.11	11.94
Long-Term Accounts Receivable	-	-	-	0	0
Other Long-Term Assets	662.19	623.51	83	117.09	218.03
Total Assets	22,031	28,093	31,018	20,959	18,840
Accounts Payable	634.55	250.65	386.05	1,116	485.06
Accrued Expenses	162.99	212.78	250.12	341.01	401.94
Short-Term Debt	6,298	9,142	9,543	9,147	3,140
Current Portion of Long-Term Debt	603.84	399.08	166.56	773.78	55.45
Current Portion of Leases	90.06	89.38	21.09	19.92	24.95
Other Current Liabilities	5,800	1,174	1,426	1,229	1,387
Total Current Liabilities	13,589	11,268	11,793	12,626	5,495
Long-Term Debt	3,225	3,513	3,012	3,179	3,952
Long-Term Leases	555.48	466.24	28.1	49.18	65.3
Long-Term Deferred Tax Liabilities	192.54	205.32	-	-	-
Other Long-Term Liabilities	-	0	-	-	-
Total Liabilities	17,614	15,525	14,833	15,854	9,513
Common Stock	4,570	4,570	4,570	3,847	1,267
Additional Paid-In Capital	25,713	27,257	27,257	18,293	20,582
Retained Earnings	-22,534	-16,431	-13,574	-16,270	-13,606
Comprehensive Income & Other	-2,119	-2,004	-2,068	-763.03	1,084
Total Common Equity	5,631	13,393	16,185	5,106	9,327
Minority Interest	-1,709	-2,545	-	-	-
Shareholders' Equity	4,417	12,569	16,185	5,106	9,327
Total Liabilities & Equity	22,031	28,093	31,018	20,959	18,840
Total Debt	10,773	13,610	12,771	13,168	7,238
Net Cash (Debt)	-7,451	-4,196	-4,143	-10,388	-4,396
Net Cash Per Share	-815.14	-459.08	-410.96	-1351.57	-879.51
Filing Date Shares Outstanding	9.14	9.14	9.14	7.69	5
Total Common Shares Outstanding	9.14	9.14	9.14	7.69	5
Working Capital	-5,758	2,149	2,330	-3,954	1,754
Book Value Per Share	616.06	1465.20	1770.73	663.67	1866.18
Tangible Book Value	3,541	11,237	16,183	5,100	9,316
Tangible Book Value Per Share	387.39	1229.37	1770.47	663.00	1863.79
Land	3,868	3,868	3,868	641.06	641.06
Buildings	4,258	4,323	4,455	4,586	4,491
Machinery	1,107	1,411	1,729	2,201	318.5
Construction In Progress	60	14.4	117.47	2,784	1,864

Source: S&P Capital IQ. Standard template. Financial Sources.